| Home | E-Submission | Sitemap | Editorial Office |  
top_img
  
ORIGINAL ARTICLE
Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
Background/Aims: Hepatitis C virus (HCV) replicates in the peripheral blood mononuclear cells (PBMCs), leading to the production of type I interferons (IFNs). It is well known that the gene expression profile of PBMC is similar to that of the liver. The present study explored th...
ORIGINAL ARTICLE
Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study
Background/Aims: Sofosbuvir plus ribavirin is a standard treatment for patients infected with chronic hepatitis C virus (HCV) genotype 2 in Korea. The purpose of this study was to examine the efficacy and safety of this treatment in Korean patients with chronic HCV genotype 2 in...
Current Issue
Volume 24(3); Sep 2018
Volume 24(2); June 2018
Volume 24(1); March 2018
Volume 23(4); December 2017
Volume 23(3); September 2017
RSS feed
Reviews
169 2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
The Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol.2018;24(3):169-229.   Published online August 10, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1004
                                 Cited By 1
230 KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications
The Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol.2018;24(3):230-277.   Published online July 9, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1005
                              Supplementary         Cited By 1
278 Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL
Jong Eun Yeon
Clin Mol Hepatol.2018;24(3):278-293.   Published online May 2, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1002
                              
Editorials
294 Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?
Jong Eun Yeon
Clin Mol Hepatol.2018;24(3):294-296.   Published online September 11, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1009
                              
297 Prognostic implications of trunk muscle mass in liver cirrhosis
Jimin Han, Won Kim
Clin Mol Hepatol.2018;24(3):297-298.   Published online September 10, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0069
                              
299 Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?
Yong Kyun Cho
Clin Mol Hepatol.2018;24(3):299-301.   Published online September 7, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1006
                              
Original Articles
302 Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
Pil Soo Sung, Eun Byul Lee, Dong Jun Park, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clin Mol Hepatol.2018;24(3):302-310.   Published online March 12, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0074
                              
311 Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study
Young Min Kim, Suk Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae, Myeong Jun Song, Ji Woong Jang, Soon Young Ko, Jae Dong Lee
Clin Mol Hepatol.2018;24(3):311-318.   Published online June 4, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0070
                                 Cited By 2
319 Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis
Dae Hoe Gu, Moon Young Kim, Yeon Seok Seo, Sang Gyune Kim, Han Ah Lee, Tae Hyung Kim, Young Kul Jung, Altay Kandemir, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um
Clin Mol Hepatol.2018;24(3):319-330.   Published online April 30, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0077
                                 Cited By 2
331 Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease
Saba Sayari, Hassan Neishaboori, Maryam Jameshorani
Clin Mol Hepatol.2018;24(3):331-338.   Published online June 12, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0006
                                 Cited By 2
Case Report
339 Adefovir-induced Fanconi syndrome associated with osteomalacia
Samel Park, Woo-Il Kim, Dai-Hyun Cho, Yeo-Joo Kim, Hong-Soo Kim, Ji-Hee Kim, Seung-Kuy Cha, Kyu-Sang Park, Ji-Hye Lee, Sang Mi Lee, Eun Young Lee
Clin Mol Hepatol.2017;24(3):339-344.   Published online September 1, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0009
                              
Letter to the Editor
345 Transarterial embolization for the treatment of complicated liver hemangiomas: A report of two cases and review of the literature
Maria Kalogirou, Danai Chourmouzi, Ioannis Dedes, Stefania Kiapidou, Evangelos Akriviadis, Emmanouil Sinakos
Clin Mol Hepatol.2018;24(3):345-349.   Published online June 11, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0075
                              
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.